Analysis of time-intensity Curves for the hepatic phases in Contrast Enhanced uLtrasonography with Perflubutane

Analysis of time-intensity Curves for the hepatic phases in Contrast Enhanced uLtrasonography with Perflubutane - ACCEL-P

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019889

Enrollment

Registered

2015-12-01

Start date

2015-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healty people

Interventions

After perfurlbutan 0.5ml was injected into the route of administration , and saline 10ml at a rate 3.0ml / sec using SmartShot.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The person can be the recognition of the abdominal aorta and portal vein in the abdominal ultrasonography .

Exclusion criteria

Exclusion criteria: The person allergic to perfulbutane.

Design outcomes

Primary

Measure	Time frame
Artery phase and portal venous phase in CEUS.	—

Secondary

Measure	Time frame
Adverse effect and complication	—

Countries

Japan

Contacts

Public ContactShintaro MIKAMI

National Center for Global health and Medicine Gastroenterology and Hepatology

me_car_3@mail.goo.ne.jp03-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026